Sjogren's syndrome: Autoimmune epithelitis

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 1, 2000, Pages 73-95

  Manoussakis, Menelaos N ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autoantibodies; Autoimmune epithelitis; Autoimmune exocrinopathy; Autoimmune rheumatic diseases; Diagnosis; Differential diagnosis; Epithelial cells; Exocrine glands; Lymphoma; Primary Sjogren's syndrome; Secondary Sjogren's syndrome; Severity index; Sjogren's syndrome

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BICARBONATE; BROMHEXINE; CLOTRIMAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DRUG; ESTROGEN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LIPOPROTEIN; METHOTREXATE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; PILOCARPINE; PREDNISONE; RIBONUCLEOPROTEIN;

ADULT; AMYLOIDOSIS; ATROPHY; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CANDIDIASIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EPITHELIUM; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPOPROTEIN BLOOD LEVEL; LYMPHOMA; MALE; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SJOEGREN SYNDROME; ARTICLE; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOPROLIFERATIVE DISEASE; PATHOPHYSIOLOGY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNE SYSTEM; LYMPHOPROLIFERATIVE DISORDERS; SJOGREN'S SYNDROME;

EID: 0033624115     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0078     Document Type: Article

References (50)

1. Moutsopoulos H M, Chused T M, Mann D L. Sjögren's syndrome (sicca syndrome): current issues. Annals of Internal Medicine. 92:1980;212-226.
2. Manoussakis M N, Talal N, Moutsopoulos H M. Sjögren's syndrome. Rose N R, Mackay I R. The Autoimmune Diseases. 1998;381-404 Academic Press, San Diego.
3. Jacobsson L TH, Axell T E, Hansen B U. Dry eyes or mouth. An epidemiological study in Swedish adults with special reference to primary Sjögren's syndrome. Journal of Autoimmunity. 2:1989;521-527.
4. Dafni U G, Tzioufas A G, Staikos P. Prevalence of Sjögren's syndrome in a closed rural community. Annals of the Rheumatic Diseases. 56:1997;521-525.
5. Moutsopoulos H M. Sjögren's syndrome: autoimmune epithelitis. Clinical Immunology Immunopathology. 72:1994;162-165.
6. Castro-Poltronieri A, Alarcon-Segovia D. Articular manifestation of primary Sjögren's syndrome. Journal of Rheumatology. 10:1983;485-490.
7. Papiris S A, Kassan S, Moutsopoulos H M. Lung involvement in Sjögren's syndrome. Seminars in Respiratory and Critical Care Medicine. 20:1999;179-184.
8. Tsianos E V, Hoofnagle J H, Fox P C. Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology. 11:1990;730-734.
9. Kassan S S, Talal N. Renal disease with Sjögren's syndrome. Talal N, Moutsopoulos H M, Kassan S S. Sjögren's Syndrome. Clinical and Immunological Aspects. 1987;96-101 Springer-Verlag, Berlin.
10. Tektonidou M, Kaskani E, Skopouli F N, Moutsopoulos H M. Microvascular abnormalities in Sjögren's syndrome: nailfold capillaroscopy. Rheumatology. 38:1999;826-830.
11. Tsokos M, Lazarou S A, Moutsopoulos H M. Vasculitis in primary Sjögren's syndrome: histologic classification and clinical presentation. American Journal of Clinical Pathology. 88:1987;26-31.
12. Drosos A A, Antonopoulos A P, Lagos G. Neuropsychiatric abnormalities in primary Sjögren's syndrome. Clinical and Experimental Rheumatology. 7:1989;207-209.
13. Malinow K L, Molina R, Gordon B. Neuropsychiatric dysfunction in primary Sjögren's syndrome. Annals of Internal Medicine. 103:1985;344-349.
14. Ioannidis J PA, Moutsopoulos H M. Sjögren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. Seminars in Arthritis and Rheumatism. 29:1999;1-3.
15. Johnson E O, Vlachoyiannopoulos P G, Skopouli F N. Hypofunction of the stress axis in Sjögren's syndrome. Journal of Rheumatology. 25:1998;1508-1514.
16. Skopouli F N, Papanikolaou S, Malamou-Mitsi V D. Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 53:1994;569-573.
17. Bunim J J, Talal N. The association of malignant lymphoma with Sjögren's syndrome. Transactions of the Association of American Physicians. 76:1963;45-56.
18. Kassan S S, Thomas T, Moutsopoulos H M. Increased risk of lymphoma in sicca syndrome. Annals of Internal Medicine. 89:1978;888-892.
19. Fox R I, Koh K, Saito I. Lymphoproliferative disorders in Sjögren's syndrome. Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M. Sjögren's Syndrome. State of the Art. 1994;199-203 Kugler, Amsterdam.
20. Voulgarelis M, Dafni U G, Isenberg D A. Malignant lymphoma in primary Sjögren's syndrome. Arthritis and Rheumatism. 42:1999;1765-1772.
21. Tzioufas A G, Boumba D A, Skopouli F N, Moutsopoulos H M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predicting factors for development of lymphoma in primary Sjögren's syndrome. Arthritis and Rheumatism. 39:1996;767-772.
22. Moutsopoulos H M, Manoussakis M N. Lumping or splitting autoimmune rheumatic disorders? Lessons from Sjögren's syndrome. British Journal of Rheumatology. 37:1998;1263-1264.
23. Moutsopoulos H M, Webber B L, Vlagopoulos T P. Differences in the clinical presentation of sicca syndrome in the presence and in the absence of rheumatoid arthritis. American Journal of Medicine. 66:1979;733-736.
24. Andonopoulos A P, Skopouli F N, Dimou G S. Sjögren's syndrome in systemic lupus erythematosus. Journal of Rheumatology. 17:1990;201-204.
25. Medsger T A Jr. Sjögren's syndrome and systemic sclerosis (scleroderma). Talal N, Moutsopoulos H M, Kassan S S. Sjögren's Syndrome. Clinical and Immunological Aspects. 1987;182-187 Springer-Verlag, Berlin.
26. Drosos A A, Pennec Y L, Elisaf M. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma. Journal of Rheumatology. 18:1991;1685-1688.
27. Vlachoyiannopoulos P G, Drosos A A, Wiik A, Moutsopoulos H M. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. British Journal of Rheumatology. 32:1993;297-301.
28. Fox R I, Kang H I, Ando D. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. Journal of Immunology. 152:1994;5532-5539.
29. Skopouli F N, Moutsopoulos H M. Cytokines in Sjögren's syndrome. Brennan F M, Feldmann M. Cytokines in Autoimmunity. 1996;121-136 R.G. Landes Company, Austin.
30. Polihronis M, Tapinos N I, Theocharis S E. Modes of epithelial cell death and repair in Sjögren's syndrome. Clinical Experimental Immunology. 114:1998;485-490.
31. Manoussakis M N, Dimitriou I D, Kapsogeorgou E K. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis and Rheumatism. 42:1999;229-239.
32. Xanthou G, Tapinos N I, Polihronis M. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clinical Experimental Immunology. 118:1999;154-163.
33. Harley J B. Autoantibodies in Sjögren's syndrome. Talal N, Moutsopoulos H M, Kassan S S. Sjögren's Syndrome. Clinical and Immunological Aspects. 1987;218-234 Springer-Verlag, Berlin.
34. Vitali C, Bombardieri S, Moutsopoulos H M. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Annals of Rheumatic Disease. 55:1996;116-121.
35. Manoussakis M N, Tzioufas A G, Pange P JE, Moutsopoulos H M. Serological profiles in subgroups of patients with Sjögren's syndrome. Scandinavian Journal of Rheumatology. 61:1986;89-92.
36. Haneji N, Nakamura T, Takio K. Identification of a-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science. 276:1997;604-607.
37. Schmid U, Helbron D, Lennert K. Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome). Virchows Archives. 395:1982;11-41.
38. Tapinos N I, Polihronis M, Moutsopoulos H M. Lymphoma in Sjögren's syndrome. Novel p53 mutations. Arthritis and Rheumatism. 42:1999;1466-1472.
39. Mann D. Immunogenetics of Sjögren's syndrome. Talal N, Moutsopoulos H M, Kassan S S. Sjögren's Syndrome. Clinical and Immunological Aspects. 1987;235-243 Springer-Verlag, Berlin.
40. Harley J B, Reichlin M, Arnett F C. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science. 232:1986;1145-1147.
41. Roitberg-Tambur A, Friedmann A, Safirmann C. Molecular analysis of HLA class II genes in primary Sjögren's syndrome: a study of Israeli and Greek non-Jewish patients. Human Immunology. 36:1993;235-242.
42. Fox R I, Koh K, Saito I. Viral factors in the etiology of Sjögren's syndrome. Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M. Sjögren's Syndrome. State of the Art. 1994;163-169 Kugler, Amsterdam.
43. Haddad J, Deny P, Munz-Gothiel C. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis-C virus liver disease. Lancet. 339:1992;321-323.
44. Chisholm D M, Mason D K. Labial salivary gland biopsy in Sjögren's syndrome. Journal of Clinical Pathology. 21:1968;656-660.
45. Itescu S. Diffuse infiltrative lymphocytosis syndrome in human immunodeficiency virus infection - a Sjögren's-like disease. Rheumatic Disease Clinics of North America. 17:1991;99-115.
46. Drosos A A, Antonopoulos A P, Costopoulos J S. Prevalence of primary Sjögren's syndrome in an elderly population. British Journal of Rheumatology. 27:1988;123-127.
47. Vlachoyiannopoulos P G, Moutsopoulos H M. Therapy in Sjögren's syndrome. Van de Putte L BA, Furst D E, Williams H J, Van Riel P LCM. Therapy of Systemic Rheumatic Disorders. 1997;615-628 Marcel Dekker, New York.
48. Linardaki G, Moutsopoulos H M. The uncertain role of immunosuppressive agents in Sjögren's syndrome. Cleveland Clinic Journal of Medicine. 64:1997;523-526.
49. Fox P C, Atkinson J C, Macynski A A. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Archives of Internal Medicine. 151:1991;1149-1152.
50. Fox R I, Chan E, Bentol L. Treatment of primary Sjögren's syndrome with hydroxychloroquine. American Journal of Medicine. 85:1988;62-67.